Small molecules(2) Integrin inhibitors(1) biologics(1) Biologic therapy(1) vedolizumab(1) Safety(1) Crohn disease(1) Tofacitinib(1) Ulcerative colitis (UC)(1) Inflammatory bowel disease(1) Therapeutic Drug Monitoring(1) Crohn’s disease (CD)(1) elderly(1) ulcerative colitis(1) inflammatory bowel disease (IBD)(1) Efficacy(1) children(1) pediatric inflammatory bowel disease(1)